Study NCT00062660   Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: June 10, 2003   Last Updated: October 12, 2009   History of Changes

Study Status:	Expanded access is currently available for this treatment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)